REGN88

SAR153191 · Sanofi and Regeneron

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN88, covering 2017-06-21 to 2017-06-21. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis [Phase 2]